12/23/2025
GLP-1 agonists are redefining the connection between metabolism and brain health—shaping cellular energy balance, inflammatory pathways, and long-term neuroinflammation. Early evidence suggests these mechanisms may play a role in altering Alzheimer’s pathology, offering a new perspective on how metabolic therapies influence cognitive health.
https://www.beyond-health.com/